XILORTA Trademark

Trademark Overview

On Monday, October 12, 2015, a trademark application was filed for XILORTA with the United States Patent and Trademark Office. The USPTO has given the XILORTA trademark a serial number of 79176000. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, April 21, 2023. This trademark is owned by IPSEN PHARMA S.A.S Hélène Bernard-Boyle. The XILORTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of endocrine diseases and disorders, gastroenterological diseases and disorders, oncological diseases and disorders, urological diseases and disorders, but excluding pharmaceutical preparations for the treatment and prevention of central nervous system diseases and disorders and neurological diseases and disorders
xilorta

General Information

Serial Number79176000
Word MarkXILORTA
Filing DateMonday, October 12, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, April 21, 2023
Registration Number5051801
Registration DateTuesday, October 4, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of endocrine diseases and disorders, gastroenterological diseases and disorders, oncological diseases and disorders, urological diseases and disorders, but excluding pharmaceutical preparations for the treatment and prevention of central nervous system diseases and disorders and neurological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIPSEN PHARMA S.A.S Hélène Bernard-Boyle
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameIPSEN PHARMA S.A.S Hélène Bernard-Boyle
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameIPSEN PHARMA S.A.S Hélène Bernard-Boyle
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Monday, February 5, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, January 6, 2024GENERIC MADRID TRANSACTION SENT TO IB
Saturday, January 6, 2024GENERIC MADRID TRANSACTION CREATED
Thursday, December 21, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 21, 2023CANCELLED SECTION 71
Monday, October 4, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 23, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, February 7, 2017GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, February 7, 2017GENERIC MADRID TRANSACTION CREATED
Wednesday, January 4, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, October 12, 2016NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, October 4, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, July 19, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 29, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 29, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 29, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 2, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 2, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 2, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 20, 2016REFUSAL PROCESSED BY IB
Thursday, February 4, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 4, 2016REFUSAL PROCESSED BY MPU
Thursday, February 4, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 3, 2016NON-FINAL ACTION WRITTEN
Tuesday, February 2, 2016ASSIGNED TO EXAMINER
Friday, November 20, 2015APPLICATION FILING RECEIPT MAILED
Monday, November 16, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, November 15, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

xilorta diseases disorders pharmaceutical prevention preparations treatment system nervous neurological central